Abstract SARS-CoV-2, a novel coronavirus, is the agent responsible for the COVID-19
pandemic and is a major public health concern nowadays. The rapid and global spread of …

With more than 5 million fatalities and close to 300 million reported cases, COVID-19 is the
first documented pandemic due to a coronavirus that continues to be a major health …

Antiviral drugs such as Remdesivir (Veklury), Nirmatrelvir with Ritonavir (Paxlovid),
Azvudine, and Molnupiravir (Lagevrio) can reduce the risk for severe and fatal Coronavirus …

The rapid spread of the SARS-CoV-2 virus has emphasized the urgent need for effective
therapies to combat COVID-19. Investigating the potential targets, inhibitors, and in silico …

In this work, a sensitive and cost-effective voltammetric method was proposed for the
determination of daclatasvir dihydrochloride (DAC. 2HCl) at a bimetallic Ag/Co …

This systematic review and meta-analysis examined the efficacy of sofosbuvir-based
antiviral treatment against COVID-19 (coronavirus disease 2019). PubMed, Embase …

RNA-dependent RNA polymerase (RdRp) is a unique and highly conserved enzyme across
all members of the RNA virus superfamilies. Besides, humans do not have a homolog of this …

Introduction Develo** and evaluating novel compounds for treatment or prophylaxis of
emerging infectious diseases is costly and time-consuming. Repurposing of already …

Daclatasvir dihydrochloride (DAC) is an anti-hepatitis C virus (HCV) drug that has recently
proven to be a promising candidate for the treatment of SARS-CoV-2. Still, there is a lack of …

Objective This study aimed to explore the efficacy and safety of small-molecule antivirals for
treating coronavirus disease 2019 (COVID-19). Methods Seven databases were searched …